ADRB2 and Hypertension: In animals, adrenaline, noradrenaline, and dopamine signal by binding to specific adrenergic, noradrenergic, and dopaminergic receptors; catecholamine receptor binding can be prevented using an antagonist specific to the catecholamine receptor, a strategy which has been utilised in treating human health conditions such as hypertension [15].